Rankings
▼
Calendar
BSX Q4 2018 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
Q4 2018 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.6B
+6.4% YoY
Gross Profit
$1.7B
65.4% margin
Operating Income
$424M
16.6% margin
Net Income
$386M
15.1% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
+7.0%
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
-$87M
Stock-Based Comp.
$140M
Balance Sheet
Total Assets
$21.0B
Total Liabilities
$12.3B
Stockholders' Equity
$8.7B
Cash & Equivalents
$146M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.6B
$2.4B
+6.4%
Gross Profit
$1.7B
$1.6B
+4.2%
Operating Income
$424M
$444M
-4.5%
Net Income
$386M
-$615M
+162.8%
Revenue Segments
Cardiovascular
$971M
55%
MedSurg
$799M
45%
Geographic Segments
UNITED STATES
$1.5B
57%
Non-US
$1.1B
43%
← FY 2018
All Quarters
Q1 2019 →